Oncotelic Therapeutics, Inc.·4

Sep 28, 9:15 AM ET

Trieu Vuong 4

4 · Oncotelic Therapeutics, Inc. · Filed Sep 28, 2022

Insider Transaction Report

Form 4
Period: 2022-09-26
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2022-09-26$0.07/sh+20,000$1,36090,368,021 total
Holdings
  • Common Stock

    (indirect: By Autotelic, Inc.)
    16,780,384
  • Common Stock

    (indirect: By Spouse)
    6,872,529

Documents

1 file
  • 4
    ownership.xmlPrimary